Cell-based Biotech Firm Bluu Biosciences Closes Seed Round After Securing €7 Million
Bluu Biosciences, a Berlin-based biotech company looking to produce cell-based fish closed its seed funding round at €7 Million.
The company said it is the first in Europe to specialize in cell-based fish production. The new capital will be used in the company’s “intensive biotechnology research and development work as well as into product development.”
Bluu Biosciences said leading global food and impact investors such as Manta Ray Ventures (UK), CPT Capital (UK), Lever VC (USA), Norrsken (SE) and Be8 (GER) participated in the investment round...
To Read Full Story Login Below.